{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:53Z","timestamp":1790400413058,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250441-4\"><jats:title>Importance<\/jats:title><jats:p>Sickle cell disease (SCD) is a complex hemoglobinopathy. Vaso-occlusive episodes are the primary cause of emergency department (ED) utilization among individuals with SCD. Literature lacks a standardized definition for high ED utilization.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-5\"><jats:title>Objective<\/jats:title><jats:p>To explore ED utilization, redefine high ED utilization, and describe factors associated with super-high ED utilization among individuals with SCD.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective cohort study analyzed the North Carolina Hospital Discharge Datasets (2013-2019). Participants were included if they had SCD, defined as at least 3 SCD visits (ED, inpatient, or outpatient surgery) in a rolling 5-year period. All age groups, sexes, and payers, regardless of state of residence, were included. Data were analyzed from July 2023 to August 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-7\"><jats:title>Exposures<\/jats:title><jats:p>Variables included sex, race, ethnicity, age, age at death, distance (in miles) to the closest SCD center, number of annual ED visits, and social vulnerability index (SVI).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>To determine ED utilization categories, first the distribution of people based on the number of annual ED visits was examined, then the categories across years were identified to determine the data-informed cutoff for each category. Univariate analysis determined differences between participants based on the ED utilization category using \u03c7<jats:sup>2<\/jats:sup> tests of independence or analysis of variance, as applicable. Descriptive statistics were conducted to describe characteristics of utilization in the sample and by ED utilization group. A parsimonious multinomial regression was conducted using significant factors from the univariate analysis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-9\"><jats:title>Results<\/jats:title><jats:p>The cohort included 9964 unique patients (5364 [53.83%] female; mean [SD] age, 24.49 [17.54] years), including 9355 Black patients (93.89%), with 100\u202f188 total ED visits from 2013 to 2019. ED visits were categorized into 4 levels: low (0-1 visits per year), moderate (2-9 visits per year), high (10-32 visits per year), and super high (\u226533 visits per year). A small subset (178 patients [1.79%]) exhibited super-high ED utilization, contributing disproportionately to the total number of ED visits. Older age, younger age for in-facility deaths, and higher SVI were significantly associated with higher ED utilization. Patients with high utilization were more likely to die, die younger (eg, median [IQR] age at death, 33.0 [30.0-44.0] years in the super-high utilization group vs 50 [38.0-61.0] years in the moderate utilization group), use multiple EDs (eg, 93.8% of participants in the super-high utilization group vs 40.08% of participants in the moderate utilization group), and reside in counties more disadvantaged on socioeconomic and transportation characteristics.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250441-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cohort study of 7 years of North Carolina Hospital Discharge Data described 4 new categories of ED utilization in SCD. These categories could be used to reframe how high ED use is determined.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.13361","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:01:09Z","timestamp":1748876469000},"page":"e2513361","source":"Crossref","is-referenced-by-count":11,"title":["Redefining High Emergency Department Utilization for Sickle Cell Disease"],"prefix":"10.1001","volume":"8","author":[{"given":"Paula","family":"Tanabe","sequence":"first","affiliation":[{"name":"Duke University School of Nursing, Durham, North Carolina"},{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[{"name":"Duke University School of Nursing, Durham, North Carolina"},{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey L.","family":"Blewer","sequence":"additional","affiliation":[{"name":"Duke University School of Nursing, Durham, North Carolina"},{"name":"Department of Family Medicine and Community Health, Duke University School of Medicine, Durham, North Carolina"},{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hatch","sequence":"additional","affiliation":[{"name":"Duke University School of Nursing, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Reyes","sequence":"additional","affiliation":[{"name":"Duke Office of Clinical Research, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Siewny","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"},{"name":"Division of Hematology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Division of Pediatric Hematology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Young","sequence":"additional","affiliation":[{"name":"Wake Emergency Physicians, Professional Association, Cary, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Kayle","sequence":"additional","affiliation":[{"name":"Duke University School of Nursing, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"4","key":"zoi250441r1","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3S","key":"zoi250441r2","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017.","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"11","key":"zoi250441r3","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00277-020-04233-w","article-title":"Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.","volume":"99","author":"Desai","year":"2020","journal-title":"Ann Hematol"},{"issue":"1","key":"zoi250441r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100158","article-title":"Characteristics of emergency department visits made by individuals with sickle cell disease in the U.S., 1999-2020.","volume":"3","author":"Attell","year":"2023","journal-title":"AJPM Focus"},{"issue":"5","key":"zoi250441r5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216414","article-title":"Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: the emergency department providers\u2019 perspective.","volume":"14","author":"Masese","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"zoi250441r6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.15537\/smj.2020.12.05585","article-title":"The relation between regular outpatient follow-up and frequency of emergency department visits in sickle cell pediatric patients.","volume":"41","author":"Ismail","year":"2020","journal-title":"Saudi Med J"},{"issue":"4","key":"zoi250441r7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/AJP.0b013e3182579b87","article-title":"A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.","volume":"29","author":"Carroll","year":"2013","journal-title":"Clin J Pain"},{"issue":"1","key":"zoi250441r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51734","article-title":"Prevalence of behavioral flags in the electronic health record among black and white patients visiting the emergency department.","volume":"6","author":"Agarwal","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi250441r9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.annemergmed.2008.07.050","article-title":"Comparisons of high versus low emergency department utilizers in sickle cell disease.","volume":"53","author":"Aisiku","year":"2009","journal-title":"Ann Emerg Med"},{"issue":"2","key":"zoi250441r10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jen.2005.02.008","article-title":"A descriptive study of heavy emergency department users at an academic emergency department reveals heavy ED users have better access to care than average users.","volume":"31","author":"Blank","year":"2005","journal-title":"J Emerg Nurs"},{"issue":"9","key":"zoi250441r11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/ajh.25168","article-title":"Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: the role of non-hematologic characteristics and baseline chronic opioid dose.","volume":"93","author":"Carroll","year":"2018","journal-title":"Am J Hematol"},{"issue":"1","key":"zoi250441r12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpainsymman.2013.08.020","article-title":"Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.","volume":"48","author":"Ezenwa","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"zoi250441r13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22700","article-title":"Health care utilization by adolescent\/young adult patients with sickle cell disease in Delaware.","volume":"14","author":"Guarino","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"zoi250441r14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069075","article-title":"Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007-2018 National Health Interview Survey (NHIS).","volume":"13","author":"Gyamfi","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"zoi250441r15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0196-0644(95)70328-4","article-title":"Health insurance status and the use of emergency and other outpatient services by adults with sickle cell disease.","volume":"25","author":"Hand","year":"1995","journal-title":"Ann Emerg Med"},{"issue":"2","key":"zoi250441r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247324","article-title":"Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations.","volume":"16","author":"Kidwell","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"zoi250441r17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1062860617707262","article-title":"A multidisciplinary approach to impact acute care utilization in sickle cell disease.","volume":"33","author":"Powell","year":"2018","journal-title":"Am J Med Qual"},{"issue":"1","key":"zoi250441r18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/bloodadvances.2023010813","article-title":"Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease.","volume":"8","author":"MacEwan","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"zoi250441r19","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.ajem.2015.07.015","article-title":"Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.","volume":"33","author":"Glassberg","year":"2015","journal-title":"Am J Emerg Med"},{"key":"zoi250441r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.08.293","article-title":"Emergency department utilization by Californians with sickle cell disease, 2005-2014.","author":"Paulukonis","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"zoi250441r21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pbc.22979","article-title":"Sickle cell disease in California: sociodemographic predictors of emergency department utilization.","volume":"58","author":"Wolfson","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"zoi250441r23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29685","article-title":"Healthcare utilization and the quality of life of children and adolescents with sickle cell disease.","volume":"69","author":"Moody","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"zoi250441r24","first-page":"80","article-title":"Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients.","volume":"110","author":"Yang","year":"1995","journal-title":"Public Health Rep"},{"issue":"3","key":"zoi250441r25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0033354919839072","article-title":"Improving an administrative case definition for longitudinal surveillance of sickle cell disease.","volume":"134","author":"Snyder","year":"2019","journal-title":"Public Health Rep"},{"issue":"10","key":"zoi250441r27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ajh.21515","article-title":"The course and correlates of high hospital utilization in sickle cell disease: evidence from a large, urban Medicaid managed care organization.","volume":"84","author":"Carroll","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"zoi250441r28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3122\/jabfm.2020.01.190143","article-title":"Sickle-cell disease co-management, health care utilization, and hydroxyurea use.","volume":"33","author":"Crego","year":"2020","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"zoi250441r29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilization for adult sickle cell patients: the PiSCES Project.","volume":"15","author":"McClish","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"zoi250441r30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jen.2017.04.009","article-title":"Identifying social-behavioral health needs of adults with sickle cell disease in the emergency department.","volume":"43","author":"Smith","year":"2017","journal-title":"J Emerg Nurs"},{"issue":"20","key":"zoi250441r31","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words\u2014racism and sickle cell disease.","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi250441r32","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/MPH.0000000000001669","article-title":"Social determinants of health and emergency department use among children with sickle cell disease.","volume":"42","author":"Cortright","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"zoi250441r33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/NCM.0000000000000356","article-title":"Implementation of an emergency department screening and care management referral process for patients with sickle cell disease.","volume":"24","author":"Rushton","year":"2019","journal-title":"Prof Case Manag"},{"issue":"12","key":"zoi250441r35","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"20","key":"zoi250441r36","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1182\/bloodadvances.2023012439","article-title":"Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.","volume":"8","author":"Siewny","year":"2024","journal-title":"Blood Adv"},{"key":"zoi250441r22","unstructured":"Wilson-Fredrick? S, Hulihan? M, Mangum? A, . Medicaid and CHIP sickle cell disease report, T-MSIS Analytic Files (TAF) 2017. Accessed March 10, 2024. https:\/\/www.medicaid.gov\/medicaid\/quality-of-care\/downloads\/scd-rpt-jan-2021.pdf?"},{"key":"zoi250441r26","unstructured":"Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, Geospatial Research A, and Services Program. Social Vulnerability Index Database. Accessed March 10, 2024. https:\/\/www.atsdr.cdc.gov\/place-health\/php\/svi\/svi-data-documentation-download.html"},{"key":"zoi250441r34","unstructured":"US Department of Health and Human Services; National Heart, Lung, and Blood Institute. Evidence-based management of sickle cell disease, expert panel report, 2014. Accessed February 21, 2015. https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834751\/tanabe_2025_oi_250441_1747934267.82025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:01:11Z","timestamp":1748876471000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.13361","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}